LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 150

Search options

  1. Article ; Online: Cholecystokinin Activation of Cholecystokinin 1 Receptors: a Purkinje Cell Neuroprotective Pathway.

    Orr, Harry T

    Cerebellum (London, England)

    2022  Volume 22, Issue 4, Page(s) 756–760

    Abstract: This is a summary of the virtual presentation given at the 2021 meeting of the Society for Research on the Cerebellum and Ataxias, https://www.meetings.be/SRCA2021/ , where the therapeutic potential of the CCK-CCK1R pathway for treating diseases ... ...

    Abstract This is a summary of the virtual presentation given at the 2021 meeting of the Society for Research on the Cerebellum and Ataxias, https://www.meetings.be/SRCA2021/ , where the therapeutic potential of the CCK-CCK1R pathway for treating diseases involving Purkinje cell degeneration was presented. Spinocerebellar ataxia type 1 (SCA1) is one of a group of almost 50 genetic diseases characterized by the degeneration of cerebellar Purkinje cells. The SCA1 Pcp2-ATXN1[30Q]D776 mouse model displays ataxia, i.e. Purkinje cell dysfunction, but lacks progressive Purkinje cell degeneration. RNA-seq revealed increased expression of cholecystokinin (CCK) in cerebella of Pcp2-ATXN1[30Q]D776 mice. Importantly, the absence of Cck1 receptor (CCK1R) in Pcp2-ATXN1[30Q]D776 mice conferred a progressive degenerative disease with Purkinje cell loss. Administration of a CCK1R agonist to Pcp2-AXTN1[82Q] mice reduced Purkinje cell pathology and associated deficits in motor performance. In addition, administration of the CCK1R agonist improved motor performance of Pcp2-ATXN2[127Q] SCA2 mice. Furthermore, CCK1R activation corrected mTORC1 signaling and improved the expression of calbindin in the cerebella of AXTN1[82Q] and ATXN2[127Q] mice. These results support the Cck-Cck1R pathway is a potential therapeutic target for the treatment of diseases involving Purkinje neuron degeneration.
    MeSH term(s) Mice ; Animals ; Purkinje Cells/physiology ; Cholecystokinin/pharmacology ; Cholecystokinin/metabolism ; Receptors, Cholecystokinin/metabolism ; Ataxin-1/genetics ; Mice, Transgenic ; Spinocerebellar Ataxias/genetics ; Cerebellum/pathology ; Ataxia/genetics ; Disease Models, Animal
    Chemical Substances Cholecystokinin (9011-97-6) ; Receptors, Cholecystokinin ; Ataxin-1
    Language English
    Publishing date 2022-06-23
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2112586-7
    ISSN 1473-4230 ; 1473-4222
    ISSN (online) 1473-4230
    ISSN 1473-4222
    DOI 10.1007/s12311-022-01428-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: HD and SCA1: Tales from two 30-year journeys since gene discovery.

    Thompson, Leslie M / Orr, Harry T

    Neuron

    2023  Volume 111, Issue 22, Page(s) 3517–3530

    Abstract: One of the more transformative findings in human genetics was the discovery that the expansion of unstable nucleotide repeats underlies a group of inherited neurological diseases. A subset of these unstable repeat neurodegenerative diseases is due to the ...

    Abstract One of the more transformative findings in human genetics was the discovery that the expansion of unstable nucleotide repeats underlies a group of inherited neurological diseases. A subset of these unstable repeat neurodegenerative diseases is due to the expansion of a CAG trinucleotide repeat encoding a stretch of glutamines, i.e., the polyglutamine (polyQ) repeat neurodegenerative diseases. Among the CAG/polyQ repeat diseases are Huntington's disease (HD) and spinocerebellar ataxia type 1 (SCA1), in which the expansions are within widely expressed proteins. Although both HD and SCA1 are autosomal dominantly inherited, and both typically cause mid- to late-life-onset movement disorders with cognitive decline, they each are characterized by distinct clinical characteristics and predominant sites of neuropathology. Importantly, the respective affected proteins, Huntingtin (HTT, HD) and Ataxin 1 (ATXN1, SCA1), have unique functions and biological properties. Here, we review HD and SCA1 with a focus on how their disease-specific and shared features may provide informative insights.
    MeSH term(s) Humans ; Huntington Disease/genetics ; Spinocerebellar Ataxias/genetics ; Ataxin-1/genetics ; Proteins/genetics ; Trinucleotide Repeats ; Nervous System Diseases/genetics ; Genetic Association Studies ; Trinucleotide Repeat Expansion/genetics
    Chemical Substances Ataxin-1 ; Proteins
    Language English
    Publishing date 2023-10-19
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 808167-0
    ISSN 1097-4199 ; 0896-6273
    ISSN (online) 1097-4199
    ISSN 0896-6273
    DOI 10.1016/j.neuron.2023.09.036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer.

    Talukdar, Gourango / Orr, Harry T / Lei, Zhixin

    Human molecular genetics

    2023  Volume 32, Issue 16, Page(s) 2545–2557

    Abstract: Protein kinase R (PKR)-like endoplasmic reticulum (ER) kinase (PERK) is one of the three major sensors in the unfolded protein response (UPR). The UPR is involved in the modulation of protein synthesis as an adaptive response. Prolonged PERK activity ... ...

    Abstract Protein kinase R (PKR)-like endoplasmic reticulum (ER) kinase (PERK) is one of the three major sensors in the unfolded protein response (UPR). The UPR is involved in the modulation of protein synthesis as an adaptive response. Prolonged PERK activity correlates with the development of diseases and the attenuation of disease severity. Thus, the current debate focuses on the role of the PERK signaling pathway either in accelerating or preventing diseases such as neurodegenerative diseases, myelin disorders, and tumor growth and cancer. In this review, we examine the current findings on the PERK signaling pathway and whether it is beneficial or detrimental for the above-mentioned disorders.
    MeSH term(s) Humans ; Endoplasmic Reticulum Stress/genetics ; Neurodegenerative Diseases/metabolism ; eIF-2 Kinase/genetics ; eIF-2 Kinase/metabolism ; Unfolded Protein Response ; Neoplasms/genetics
    Chemical Substances eIF-2 Kinase (EC 2.7.11.1)
    Language English
    Publishing date 2023-06-29
    Publishing country England
    Document type Review ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1108742-0
    ISSN 1460-2083 ; 0964-6906
    ISSN (online) 1460-2083
    ISSN 0964-6906
    DOI 10.1093/hmg/ddad103
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Toxic RNA as a driver of disease in a common form of ALS and dementia.

    Orr, Harry T

    Proceedings of the National Academy of Sciences of the United States of America

    2013  Volume 110, Issue 19, Page(s) 7533–7534

    MeSH term(s) Amyotrophic Lateral Sclerosis/genetics ; Animals ; DNA Repeat Expansion ; Frontotemporal Dementia/genetics ; Humans
    Language English
    Publishing date 2013-04-29
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1305239110
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Increased intrinsic membrane excitability is associated with hypertrophic olivary degeneration in spinocerebellar ataxia type 1.

    Morrison, Logan M / Huang, Haoran / Handler, Hillary P / Fu, Min / Bushart, David D / Pappas, Samuel S / Orr, Harry T / Shakkottai, Vikram G

    bioRxiv : the preprint server for biology

    2023  

    Abstract: One of the characteristic areas of brainstem degeneration across multiple spinocerebellar ataxias (SCAs) is the inferior olive (IO), a medullary nucleus that plays a key role in motor learning. In addition to its vulnerability in SCAs, the IO is also ... ...

    Abstract One of the characteristic areas of brainstem degeneration across multiple spinocerebellar ataxias (SCAs) is the inferior olive (IO), a medullary nucleus that plays a key role in motor learning. In addition to its vulnerability in SCAs, the IO is also susceptible to a distinct pathology known as hypertrophic olivary degeneration (HOD). Clinically, HOD has been exclusively observed after lesions in the brainstem disrupt inhibitory afferents to the IO. Here, for the first time, we describe HOD in another context: spinocerebellar ataxia type 1 (SCA1). Using the genetically-precise SCA1 knock-in mouse model (SCA1-KI; both sexes used), we assessed SCA1-associated changes in IO neuron structure and function. Concurrent with degeneration, we found that SCA1-KI IO neurons are hypertrophic, exhibiting early dendrite lengthening and later somatic expansion. Unlike in previous descriptions of HOD, we observed no clear loss of IO inhibitory innervation; nevertheless, patch-clamp recordings from brainstem slices reveal that SCA1-KI IO neurons are hyperexcitable. Rather than synaptic disinhibition, we identify increases in
    Language English
    Publishing date 2023-10-23
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.10.23.563657
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cell biology of spinocerebellar ataxia.

    Orr, Harry T

    The Journal of cell biology

    2012  Volume 197, Issue 2, Page(s) 167–177

    Abstract: Ataxia is a neurological disorder characterized by loss of control of body movements. Spinocerebellar ataxia (SCA), previously known as autosomal dominant cerebellar ataxia, is a biologically robust group of close to 30 progressive neurodegenerative ... ...

    Abstract Ataxia is a neurological disorder characterized by loss of control of body movements. Spinocerebellar ataxia (SCA), previously known as autosomal dominant cerebellar ataxia, is a biologically robust group of close to 30 progressive neurodegenerative diseases. Six SCAs, including the more prevalent SCA1, SCA2, SCA3, and SCA6 along with SCA7 and SCA17 are caused by expansion of a CAG repeat that encodes a polyglutamine tract in the affected protein. How the mutated proteins in these polyglutamine SCAs cause disease is highly debated. Recent work suggests that the mutated protein contributes to pathogenesis within the context of its "normal" cellular function. Thus, understanding the cellular function of these proteins could aid in the development of therapeutics.
    MeSH term(s) Amino Acid Sequence ; Ataxin-1 ; Ataxins ; Humans ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Peptides/chemistry ; Protein Biosynthesis ; RNA Splicing Factors ; RNA-Binding Proteins/metabolism ; Signal Transduction ; Spinocerebellar Ataxias/genetics ; Trinucleotide Repeat Expansion ; Trinucleotide Repeats
    Chemical Substances ATXN1 protein, human ; Ataxin-1 ; Ataxins ; Nerve Tissue Proteins ; Nuclear Proteins ; Peptides ; RBM17 protein, human ; RNA Splicing Factors ; RNA-Binding Proteins ; polyglutamine (26700-71-0)
    Language English
    Publishing date 2012-04-16
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 218154-x
    ISSN 1540-8140 ; 0021-9525
    ISSN (online) 1540-8140
    ISSN 0021-9525
    DOI 10.1083/jcb.201105092
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Polyglutamine neurodegeneration: expanded glutamines enhance native functions.

    Orr, Harry T

    Current opinion in genetics & development

    2012  Volume 22, Issue 3, Page(s) 251–255

    Abstract: An intriguing set of neurodegenerative disease are the nine disorders caused by the expansion of a unstable trinucleotide CAG repeat where the repeat is located within the coding of the affected gene, that is, the polyglutamine (polyQ) diseases. A gain- ... ...

    Abstract An intriguing set of neurodegenerative disease are the nine disorders caused by the expansion of a unstable trinucleotide CAG repeat where the repeat is located within the coding of the affected gene, that is, the polyglutamine (polyQ) diseases. A gain-of-function mechanism for toxicity in polyQ diseases is widely thought to have a major role in pathogenesis. Yet, the specific nature of this gain-of-function is a matter of considerable discussion. The basic issue concerns whether toxicity stems from the native or normal function of the affected protein versus a novel function induced by polyQ expansion. For at least three of the polyQ disease considerable evidence is accumulating that pathology is mediated by a polyQ-induced exaggeration of a native function of the host protein.
    MeSH term(s) Animals ; Autoantigens/genetics ; Autoantigens/metabolism ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Cell Nucleus/genetics ; Cell Nucleus/metabolism ; Cilia/genetics ; Cilia/metabolism ; Glutamine/genetics ; Glutamine/metabolism ; Humans ; Huntingtin Protein ; Huntington Disease/genetics ; Huntington Disease/metabolism ; Huntington Disease/pathology ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; Peptides/genetics ; Peptides/metabolism ; Phosphorylation ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Spinocerebellar Ataxias/genetics ; Spinocerebellar Ataxias/metabolism ; Spinocerebellar Ataxias/pathology ; Structure-Activity Relationship ; Trinucleotide Repeat Expansion
    Chemical Substances AR protein, human ; Autoantigens ; Cell Cycle Proteins ; HTT protein, human ; Huntingtin Protein ; Nerve Tissue Proteins ; PCM1 protein, human ; Peptides ; Receptors, Androgen ; Glutamine (0RH81L854J) ; polyglutamine (26700-71-0)
    Language English
    Publishing date 2012-01-25
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1077312-5
    ISSN 1879-0380 ; 0959-437X
    ISSN (online) 1879-0380
    ISSN 0959-437X
    DOI 10.1016/j.gde.2012.01.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.

    Orr, Harry T

    Progress in neurobiology

    2012  Volume 99, Issue 3, Page(s) 179–185

    Abstract: Spinocerebellar ataxia type 1 (SCA1) is one an intriguing set of nine neurodegenerative diseases caused by the expansion of a unstable trinucleotide CAG repeat where the repeat is located within the coding of the affected gene, i.e. the polyglutamine ( ... ...

    Abstract Spinocerebellar ataxia type 1 (SCA1) is one an intriguing set of nine neurodegenerative diseases caused by the expansion of a unstable trinucleotide CAG repeat where the repeat is located within the coding of the affected gene, i.e. the polyglutamine (polyQ) diseases. A gain-of-function mechanism for toxicity in SCA1, like the other polyQ diseases, is thought to have a major role in pathogenesis. Yet, the specific nature of this gain-of-function is a matter of considerable discussion. An issue concerns whether toxicity stems from the native or normal function of the affected protein versus a novel function induced by polyQ expansion. For SCA1 considerable evidence is accumulating that pathology is mediated by a polyQ-induced exaggeration of a native function of the host protein Ataxin-1 (ATXN1) and that phosphorylation of S776 regulates its interaction with other cellular protein and thereby function. In addition, this posttranslational modification modulates toxicity of ATXN1 with an expanded polyglutamine.
    MeSH term(s) Animals ; Ataxin-1 ; Ataxins ; Cerebellum/metabolism ; Cerebellum/pathology ; Humans ; Nerve Tissue Proteins/metabolism ; Nuclear Proteins/metabolism ; Peptides/metabolism ; Phosphorylation/physiology ; Purkinje Cells/metabolism ; Purkinje Cells/pathology ; Spinocerebellar Ataxias/genetics ; Spinocerebellar Ataxias/metabolism ; Spinocerebellar Ataxias/pathology
    Chemical Substances ATXN1 protein, human ; Ataxin-1 ; Ataxins ; Nerve Tissue Proteins ; Nuclear Proteins ; Peptides ; polyglutamine (26700-71-0)
    Language English
    Publishing date 2012-04-16
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 185535-9
    ISSN 1873-5118 ; 0301-0082
    ISSN (online) 1873-5118
    ISSN 0301-0082
    DOI 10.1016/j.pneurobio.2012.04.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Are polyglutamine diseases expanding?

    Orr, Harry T

    Neuron

    2011  Volume 70, Issue 3, Page(s) 377–378

    Abstract: It remains a matter of speculation as to whether the sense CUG-containing RNA and/or the antisense CAG-encoding polyglutamine peptide serves as the pathogenic moiety in Huntington's disease like-2 (HDL2). In this issue of Neuron, Wilburn et al. show that ...

    Abstract It remains a matter of speculation as to whether the sense CUG-containing RNA and/or the antisense CAG-encoding polyglutamine peptide serves as the pathogenic moiety in Huntington's disease like-2 (HDL2). In this issue of Neuron, Wilburn et al. show that in a HDL2 mouse model, the polyglutamine peptide drives disease progression.
    Language English
    Publishing date 2011-05-12
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 808167-0
    ISSN 1097-4199 ; 0896-6273
    ISSN (online) 1097-4199
    ISSN 0896-6273
    DOI 10.1016/j.neuron.2011.04.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Stephen T. Warren, Ph.D. (1953-2021): A remembrance.

    Nelson, David L / Clark, Janelle / Garber, Kathryn / Glover, Thomas / Hassold, Terry / Jin, Peng / Orr, Harry T / Sherman, Stephanie L / Zoghbi, Huda / Warren, Karen L

    American journal of human genetics

    2022  Volume 109, Issue 1, Page(s) 3–11

    Language English
    Publishing date 2022-01-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 219384-x
    ISSN 1537-6605 ; 0002-9297
    ISSN (online) 1537-6605
    ISSN 0002-9297
    DOI 10.1016/j.ajhg.2021.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top